The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium. Arbli, an angiotensin II receptor blocker, is indicated for the treatment of ...
The following is a summary of “Construction of a machine learning-based interpretable prediction model for acute kidney ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...
In a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes (KDIGO) organization, a ...
Up to 30% of acute kidney injury (AKI) survivors requiring dialysis and personalized care after discharge from the hospital.
A urine test strip method using the semi-quantitative albumin-to-creatinine ratio can enhance the early detection of chronic ...
The following is a summary of “Incidence of Acute Kidney Injury After Exposure to Intravenous Contrast in Emergency ...
A Chinese medical team has successfully transplanted a gene-engineered pig kidney into a uremic patient, marking a major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback